Neuronetics
STIM
Neuronetics (STIM) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.05
- EPS estimate
- −$0.12
- EPS surprise
- +59.35%
- Revenue surprise
- +3.47%
- Revenue
- $41.6M
- Revenue estimate
- $40.2M
- Reported
- Aug 11, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 11, 2026 | −$0.12 | −$0.05 | +59.35% | $41.6M | SEC |
| Q1 2026 | May 5, 2026 | −$0.17 | −$0.16 | +8.20% | $34.5M | SEC |
| Q4 2025 | Mar 17, 2026 | −$0.11 | −$0.10 | +5.21% | $41.8M | SEC |
| Q3 2025 | Nov 4, 2025 | −$0.12 | −$0.13 | −4.17% | $37.3M | SEC |
| Q2 2025 | Aug 5, 2025 | −$0.08 | −$0.15 | −91.57% | $38.1M | SEC |
| Q1 2025 | May 6, 2025 | −$0.12 | −$0.21 | −69.63% | $32.0M | SEC |
| Q4 2024 | Mar 4, 2025 | −$0.24 | −$0.33 | −36.08% | $22.5M | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.23 | −$0.44 | −92.06% | $18.5M | SEC |
| Q2 2024 | Aug 12, 2024 | −$0.27 | −$0.33 | −22.59% | $16.4M | SEC |
| Q1 2024 | May 7, 2024 | −$0.31 | −$0.27 | +12.79% | $17.4M | SEC |
| Q4 2023 | Mar 5, 2024 | −$0.26 | −$0.19 | +26.75% | $20.3M | SEC |
| Q3 2023 | Nov 7, 2023 | −$0.31 | −$0.33 | −6.45% | $17.9M | SEC |
| Q2 2023 | Aug 8, 2023 | −$0.35 | −$0.17 | +51.08% | $17.6M | SEC |
| Q1 2023 | May 9, 2023 | −$0.39 | −$0.38 | +1.94% | $15.5M | SEC |
| Q4 2022 | Mar 7, 2023 | −$0.38 | −$0.30 | +21.01% | $18.2M | SEC |
| Q3 2022 | Nov 8, 2022 | −$0.42 | −$0.28 | +33.71% | $16.5M | SEC |
| Q2 2022 | Aug 2, 2022 | −$0.41 | −$0.39 | +5.11% | $16.3M | SEC |
| Q1 2022 | May 12, 2022 | −$0.40 | −$0.41 | −2.32% | $14.2M | SEC |
| Q4 2021 | Mar 8, 2022 | −$0.32 | −$0.29 | +8.46% | $15.0M | SEC |
| Q3 2021 | Nov 9, 2021 | −$0.30 | −$0.31 | −2.55% | $13.8M | SEC |
Quarterly revenue
Frequently asked questions
When did Neuronetics (STIM) last report earnings?
Neuronetics last reported on Aug 11, 2026, covering fiscal Q2 2026.
Did STIM beat earnings estimates?
Yes. Neuronetics reported EPS of −$0.05 for Q2 2026 against a −$0.12 estimate — a 59.35% beat.
How much revenue did STIM report last quarter?
Neuronetics reported $41.6M in revenue for Q2 2026, against a consensus estimate of $40.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.